These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 30397483)

  • 1. Comparison of patient-reported outcomes during acute exacerbations of chronic obstructive pulmonary disease.
    Nishimura K; Nakamura S; Kusunose M; Nakayasu K; Sanda R; Hasegawa Y; Oga T
    BMJ Open Respir Res; 2018; 5(1):e000305. PubMed ID: 30397483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utility of the CAT in the therapy assessment of COPD exacerbations in China.
    Tu YH; Zhang Y; Fei GH
    BMC Pulm Med; 2014 Mar; 14():42. PubMed ID: 24618290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The COPD assessment test and St George's Respiratory Questionnaire: are they equivalent in subjects with COPD?
    Morishita-Katsu M; Nishimura K; Taniguchi H; Kimura T; Kondoh Y; Kataoka K; Ogawa T; Watanabe F; Arizono S; Nishiyama O; Nakayasu K; Imaizumi K; Hasegawa Y
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1543-51. PubMed ID: 27462150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Health status of COPD patients undergoing pulmonary rehabilitation: A comparative responsiveness of the CAT and SGRQ.
    Sciriha A; Lungaro-Mifsud S; Scerri J; Magro R; Camilleri L; Montefort S
    Chron Respir Dis; 2017 Nov; 14(4):352-359. PubMed ID: 29081264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frailty and patient-reported outcomes in subjects with chronic obstructive pulmonary disease: are they independent entities?
    Kusunose M; Oga T; Nakamura S; Hasegawa Y; Nishimura K
    BMJ Open Respir Res; 2017; 4(1):e000196. PubMed ID: 28883929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparison of different evaluation systems for assessing disease severity and treatment efficacy in patients with chronic obstructive pulmonary disease].
    Tan M; Jian W; Liang Q; Li S; Cui H
    Nan Fang Yi Ke Da Xue Xue Bao; 2021 Jul; 41(7):1119-1124. PubMed ID: 34308866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Are in Person and Telephone Interviews Equivalent Modes of Administrating the CAT, the FACIT-FS and the SGRQ in People With COPD?
    Rocha V; Jácome C; Martins V; Marques A
    Front Rehabil Sci; 2021; 2():729190. PubMed ID: 36188865
    [No Abstract]   [Full Text] [Related]  

  • 8. The St. George's Respiratory Questionnaire Definition of Chronic Bronchitis May Be a Better Predictor of COPD Exacerbations Compared With the Classic Definition.
    Kim V; Zhao H; Regan E; Han MK; Make BJ; Crapo JD; Jones PW; Curtis JL; Silverman EK; Criner GJ;
    Chest; 2019 Oct; 156(4):685-695. PubMed ID: 31047955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of Predictive Properties between Tools of Patient-Reported Outcomes: Risk Prediction for Three Future Events in Subjects with COPD.
    Nishimura K; Kusunose M; Sanda R; Mori M; Shibayama A; Nakayasu K
    Diagnostics (Basel); 2023 Jul; 13(13):. PubMed ID: 37443664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COPD Assessment Test for measurement of health status in patients with idiopathic pulmonary fibrosis: A cross-sectional study.
    Matsuda T; Taniguchi H; Ando M; Kondoh Y; Kimura T; Kataoka K; Sakamoto K; Suzuki A; Furukawa T; Hasegawa Y
    Respirology; 2017 May; 22(4):721-727. PubMed ID: 27859913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adaptation and validation of the Chinese version of Dyspnoea-12 scale in individuals with chronic obstructive pulmonary disease.
    Choi TCM; Chan LLY; Tsang HC; Vong YP; Cheng YK; To YL; Choo KL; Yorke J
    Clin Respir J; 2021 Oct; 15(10):1081-1087. PubMed ID: 34145767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cross-sectional validation of the COPD Assessment Test (CAT) among chronic obstructive pulmonary disease patients in rural Uganda.
    Batte C; Semulimi AW; Mutebi RK; Twinamasiko N; Muyama SR; Mukisa J; Atukunda I; Mukunya D; Kalyesubula R; Trishul S; Kirenga B
    PLOS Glob Public Health; 2023; 3(6):e0002013. PubMed ID: 37276227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CAT Score and SGRQ Definitions of Chronic Bronchitis as an Alternative to the Classical Definition.
    Choi JY; Yoon HK; Shin KC; Park SY; Lee CY; Ra SW; Jung KS; Yoo KH; Lee CH; Rhee CK
    Int J Chron Obstruct Pulmon Dis; 2019; 14():3043-3052. PubMed ID: 31920301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A meta-analysis of four randomized clinical trials to confirm the reliability and responsiveness of the Shortness of Breath with Daily Activities (SOBDA) questionnaire in chronic obstructive pulmonary disease.
    Tabberer M; Brooks J; Wilcox T
    Health Qual Life Outcomes; 2015 Oct; 13():177. PubMed ID: 26520062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is the CAT questionnaire sensitive to changes in health status in patients with severe COPD exacerbations?
    Agustí A; Soler JJ; Molina J; Muñoz MJ; García-Losa M; Roset M; Jones PW; Badia X
    COPD; 2012 Aug; 9(5):492-8. PubMed ID: 22958111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Defining Chronic Mucus Hypersecretion Using the CAT in the SPIROMICS Cohort.
    Stott-Miller M; Müllerová H; Miller B; Tabberer M; El Baou C; Keeley T; Martinez FJ; Han M; Dransfield M; Hansel NN; Cooper CB; Woodruff P; Ortega VE; Comellas AP; Paine Iii R; Kanner RE; Anderson W; Drummond MB; Kim V; Tal-Singer R; Lazaar AL
    Int J Chron Obstruct Pulmon Dis; 2020; 15():2467-2476. PubMed ID: 33116463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychometric validation of a Hindi version of a chronic obstructive pulmonary disease (COPD) assessment test in patients in northern India.
    Aggarwal AN; Lallawmkima I; Basu D
    Natl Med J India; 2017; 30(4):193-197. PubMed ID: 29162750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blood eosinophils and treatment response with triple and dual combination therapy in chronic obstructive pulmonary disease: analysis of the IMPACT trial.
    Pascoe S; Barnes N; Brusselle G; Compton C; Criner GJ; Dransfield MT; Halpin DMG; Han MK; Hartley B; Lange P; Lettis S; Lipson DA; Lomas DA; Martinez FJ; Papi A; Roche N; van der Valk RJP; Wise R; Singh D
    Lancet Respir Med; 2019 Sep; 7(9):745-756. PubMed ID: 31281061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Performance of the EXAcerbations of chronic pulmonary disease tool patient-reported outcome measure in three clinical trials of chronic obstructive pulmonary disease.
    Leidy NK; Murray LT; Jones P; Sethi S
    Ann Am Thorac Soc; 2014 Mar; 11(3):316-25. PubMed ID: 24432712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of positive expiratory pressure (PEP) therapy on symptoms, quality of life and incidence of re-exacerbation in patients with acute exacerbations of chronic obstructive pulmonary disease: a multicentre, randomised controlled trial.
    Osadnik CR; McDonald CF; Miller BR; Hill CJ; Tarrant B; Steward R; Chao C; Stodden N; Oliveira CC; Gagliardi N; Holland AE
    Thorax; 2014 Feb; 69(2):137-43. PubMed ID: 24005444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.